[Previous] [Next]
§63-2-208.
§63-2-208.
The controlled substances listed in this section are included in
Schedule III.
A. Unless listed in another schedule, any material, compound, mixture,
or preparation, which contains any quantity of the following
substances or any other substance having a potential for abuse
associated with a stimulant or depressant effect on the central
nervous system:
1. Any substance which contains any quantity of a derivative of
barbituric acid, or any salt of a derivative of barbituric acid unless
specifically excepted or unless listed in another schedule.
2. Chlorhexadol.
3. Glutethimide.
4. Lysergic acid.
5. Lysergic acid amide.
6. Methyprylon.
7. Sulfondiethylmethane.
8. Sulfonethylmethane.
9. Sulfonmethane.
10. Benzephetamine and its salts.
11. Chlorphentermine and its salts.
12. Clortermine.
13. Mazindol.
14. Phendimetrazine.
15. Phenylacetone (P2P).
16. 1-Phenycyclohexylamine.
17. 1-Piperidinocychexanecarbo nitrile (PCC).
18. Ketamine hydrochloride.
19. Any material, compound, mixture, or preparation which contains any
quantity of the following hormonal substances or steroids, including
their salts, isomers, esters and salts of isomers and esters, when the
existence of these salts, isomers, esters, and salts of isomers and
esters is possible within the specific chemical designation:
a. Boldenone,
b. Chlorotestosterone,
c. Clostebol,
d. Dehydrochlormethyltestosterone,
e. Dihydrotestosterone,
f. Drostanolone,
g. Ethylestrenol,
h. Fluoxymesterone,
i. Formebolone,
j. Mesterolone,
k. Methandienone,
l. Methandranone,
m. Methandriol,
n. Methandrostenolone,
o. Methenolone,
p. Methyltestosterone, except as provided in subsection E of this
section,
q. Mibolerone,
r. Nandrolone,
s. Norethandrolone,
t. Oxandrolone,
u. Oxymesterone,
v. Oxymetholone,
w. Stanolone,
x. Stanozolol,
y. Testolactone,
z. Testosterone, except as provided in subsection E of this section,
and
aa. Trenbolone.
Livestock implants as regulated by the Federal Food and Drug
Administration shall be exempt.
B. Nalorphine.
C. Unless listed in another schedule, any material, compound, mixture,
or preparation containing limited quantities of any of the following
narcotic drugs, or any salts thereof:
1. Not more than one and eight-tenths (1.8) grams of codeine or any of
its salts, per one hundred (100) milliliters or not more than ninety
(90) milligrams per dosage unit, with an equal or greater quantity of
an isoquinoline alkaloid of opium;
2. Not more than one and eight-tenths (1.8) grams of codeine or any of
its salts, per one hundred (100) milliliters or not more than ninety
(90) milligrams per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts;
3. Not more than three hundred (300) milligrams of dihydrocodeinone or
any of its salts, per one hundred (100) milliliters or not more than
fifteen (15) milligrams per dosage unit, with a fourfold or greater
quantity of an isoquinoline alkaloid of opium;
4. Not more than three hundred (300) milligrams of dihydrocodeinone or
any of its salts, per one hundred (100) milliliters or not more than
fifteen (15) milligrams per dosage unit, with one or more active,
nonnarcotic ingredients in recognized therapeutic amounts;
5. Not more than one and eight-tenths (1.8) grams of dihydrocodeine or
any of its salts, per one hundred (100) milliliters or not more than
ninety (90) milligrams per dosage unit, with one or more active,
nonnarcotic ingredients in recognized therapeutic amounts;
6. Not more than three hundred (300) milligrams of ethylmorphine or
any of its salts, per one hundred (100) milliliters or not more than
fifteen (15) milligrams per dosage unit, with one or more ingredients
in recognized therapeutic amounts;
7. Not more than five hundred (500) milligrams of opium per one
hundred (100) milliliters or per one hundred (100) grams, or not more
than twenty-five (25) milligrams per dosage unit, with one or more
active, nonnarcotic ingredients in recognized therapeutic amounts;
8. Not more than fifty (50) milligrams of morphine or any of its
salts, per one hundred (100) milliliters or per one hundred (100)
grams with one or more active, nonnarcotic ingredients in recognized
therapeutic amounts.
D. The Board of Pharmacy may except by rule any compound, mixture, or
preparation containing any stimulant or depressant substance listed in
subsections A and B of this section from the application of all or any
part of the Uniform Controlled Dangerous Substances Act if the
compound, mixture, or preparation contains one or more active
medicinal ingredients not having a stimulant or depressant effect on
the central nervous system, and if the admixtures are included therein
in combinations, quantity, proportion, or concentration that vitiate
the potential for abuse of the substances which have a stimulant or
depressant effect on the central nervous system.
E. The following hormonal substances or steroids are exempt from
classification as Schedule III controlled dangerous substances:
1. Estratest, containing 1.25 mg esterified estrogens and 2.5 mg
methyltestosterone,
2. Estratest HS, containing 0.625 mg esterified estrogens and 1.25 mg
methyltestosterone;
3. Premarin with Methyltestosterone, containing 1.25 mg conjugated
estrogens and 10.0 mg methyltestosterone;
4. Premarin with Methyltestosterone, containing 0.625 mg conjugated
estrogens and 5.0 mg methyltestosterone;
5. Testosterone Cypionate - Estrodiol Cypionate injection, containing
50 mg/ml Testosterone Cypionate; and
6. Testosterone Enanthate - Estradiol Valerate injection, containing
90 mg/ml Testosterone Enanthate and 4 mg/ml Estradiol Valerate.
[Previous] [Next]